Thrombotic microangiopathy and anti-VEGF agents

被引：67
|
作者：
Izzedine, Hassane [1 ]
Brocheriou, Isabelle
Deray, Gilbert
Rixe, Olivier
机构：
[1] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Pathol, Paris, France
[3] Hop La Pitie Salpetriere, Dept Oncol, Paris, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2007年 / 22卷 / 05期
关键词：
D O I：
10.1093/ndt/gfl565
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：1481 / 1482
页数：3
相关论文
共 50 条
  • [1] Thrombotic microangiopathy related to anti-VEGF agents: intensive versus conservative treatment?
    Izzedine, H.
    Sene, D.
    Hadoux, J.
    Gharbi, C.
    Bourry, E.
    Massard, C.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 487 - U255
  • [2] EXPLORING THE RISK OF THROMBOTIC MICROANGIOPATHY (TMA) IN ANTI-VEGF THERAPY: A GLOBAL MULTICENTRIC RETROSPECTIVE ANALYSIS
    Sardar, Sundus
    Matarneh, Ahmad
    Akkari, Abdel-Raouf
    Abdulbasi, Muhammad
    Karasinski, Amanda
    Trivedi, Naman
    Verma, Navin
    Ghahramani, Nasr
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [3] Discussion - Anti-VEGF agents
    Dr. Lilenbaum
    Dr. Wakelee
    Dr. Lynch
    Dr. Socinski
    Dr. Heymach
    Dr. Jain
    Dr. Sorensen
    Dr. Janne
    Dr. Hirsch
    Dr. Engelman
    Dr. Shepherd
    Dr. Hanke
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S135 - S137
  • [4] Resistance to anti-VEGF agents
    Ton, NC
    Jayson, GC
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (01) : 51 - 64
  • [5] The use of anti-VEGF agents in pregnancy
    Gallagher, Kevin
    Brown, Ffion
    Bilal, Ahmed
    Al-Janabi, Ahmed
    Davies, Nigel
    EYE, 2024, 38 (09) : 1614 - 1615
  • [6] Anti-VEGF agents in the treatment of RVO
    Rehak, Matus
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [7] Clinicopathological analysis of anti-VEGF drug-associated renal thrombotic microangiopathy: A case series and review of the literature
    Han, Qianqian
    Li, Lin
    Li, Ziyao
    Yang, Mei
    Lei, Song
    Su, Yanyan
    Xu, Huan
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 266
  • [8] CASE 3: SWITCHING ANTI-VEGF AGENTS
    Eichenbaum, David
    Dr Singer
    Dr Holekamp
    Dr Khanani
    Dr Eichenbaum
    Dr Singer
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 : 10 - 10
  • [9] Intravitreal anti-VEGF agents and cardiovascular risk
    Massimo Porta
    Elio Striglia
    Internal and Emergency Medicine, 2020, 15 : 199 - 210
  • [10] Anti-VEGF Agents and the Risk of Arteriothrombotic Events
    Zarbin, Marco A.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2018, 7 (01): : 63 - 67
12345